SPMAC: The role of pro-resolving lipid mediators and gut-resident macrophages in regulating early-in-life immune imprinting and adulthood [...]
SPMAC:促溶解脂质介质和肠道驻留巨噬细胞在调节生命早期免疫印记和成年期中的作用[...]
基本信息
- 批准号:EP/X021122/1
- 负责人:
- 金额:$ 24.26万
- 依托单位:
- 依托单位国家:英国
- 项目类别:Fellowship
- 财政年份:2022
- 资助国家:英国
- 起止时间:2022 至 无数据
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
As we transition from milk to solid foods during weaning, the number and types of bacteria in our intestine increases. In response, our body develops defenses against the increasing number of bacteria. Interestingly, this response works as the first training or "imprinting" for our defenses systems. It teaches our defense cells to distinguish between beneficial and harmful bacteria, and to react in a balanced way against foreign microorganisms without causing too much damage to the body or exaggerate in the inflammatory response that is our body's main means of defense. If this initial training step is disrupted, the organism develops an improper imprinting that is retained throughout life, increasing the susceptibility to inflammatory diseases in the adulthood, including colitis. These diseases occur because our body exaggerates in the inflammatory response, but we still do not know how this occurs. Thus, the aim of this proposal is to answer some pertinent questions for which there is still no answer: What cells and molecules produced by our body are important for this imprinting? Could the application of such molecules later in life reverse cases of an improper early-in-life imprinting and, thus, control the susceptibility to colitis in the adulthood? These answers can help us understand how inflammatory diseases like colitis develop and reveal more effective approaches to control or treat them.
当我们在断奶期间从牛奶转向固体食物时,肠道内细菌的数量和类型都会增加。作为回应,我们的身体会对越来越多的细菌产生防御。有趣的是,这种反应是我们防御系统的第一次训练或“印记”。它教会我们的防御细胞区分有益和有害的细菌,并以一种平衡的方式对外来微生物作出反应,而不会对身体造成太大的损害,也不会加剧炎症反应,而炎症反应是我们身体的主要防御手段。如果这一最初的训练步骤被打乱,机体就会形成一种不适当的印记,并在整个生命中保留下来,从而增加成年期对炎症性疾病的易感性,包括结肠炎。这些疾病的发生是因为我们的身体夸大了炎症反应,但我们仍然不知道这是如何发生的。因此,这项提议的目的是回答一些仍然没有答案的相关问题:我们身体产生的哪些细胞和分子对这种印记很重要?这些分子在生命后期的应用能否逆转早期不适当的印记,从而控制成年期对结肠炎的易感性?这些答案可以帮助我们了解像结肠炎这样的炎症性疾病是如何发展的,并揭示更有效的控制或治疗方法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Jesmond Dalli其他文献
Stereocontrolled synthesis and investigation of the biosynthetic transformations of 16(S),17(S)-epoxy-PDn-3 DPA.
16(S),17(S)-epoxy-PDn-3 DPA 的立体控制合成和生物合成转化研究。
- DOI:
- 发表时间:
2017 - 期刊:
- 影响因子:3.2
- 作者:
K. G. Primdahl;J. Tungen;P. R. S. De Souza;R. Colas;Jesmond Dalli;T. Hansen;A. Vik - 通讯作者:
A. Vik
Reply to: Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples
回复:未能将检测限或定量限标准应用于专业的促解决介质分析,错误地描述了它们在生物样本中的存在情况。
- DOI:
10.1038/s41467-023-41767-9 - 发表时间:
2023-11-10 - 期刊:
- 影响因子:15.700
- 作者:
Jesmond Dalli;Esteban A. Gomez - 通讯作者:
Esteban A. Gomez
Immune resolution mechanisms in inflammatory arthritis
炎症性关节炎中的免疫消退机制
- DOI:
10.1038/nrrheum.2016.193 - 发表时间:
2017-01-05 - 期刊:
- 影响因子:32.700
- 作者:
Mauro Perretti;Dianne Cooper;Jesmond Dalli;Lucy V. Norling - 通讯作者:
Lucy V. Norling
Formyl Peptide Receptor 2/Lipoxin A Centered on Polymorphonuclear Leukocyte Evidence for an Anti-Inflammatory Loop
以多形核白细胞抗炎环证据为中心的甲酰肽受体 2/脂氧素 A
- DOI:
- 发表时间:
2011 - 期刊:
- 影响因子:0
- 作者:
Jesmond Dalli;Stefania Bena;R. Flower;G. Cirino;M. Perretti - 通讯作者:
M. Perretti
14,17,18-Trihydroxy-Eicosatetraenoic Acid: A Novel Pro-Resolving Lipid Mediator from Marine Microalgae.
14,17,18-三羟基-二十碳四烯酸:一种来自海洋微藻的新型促溶解脂质介质。
- DOI:
- 发表时间:
2021 - 期刊:
- 影响因子:0
- 作者:
H. Jagusch;Markus Werner;D. Koenis;Jesmond Dalli;O. Werz;G. Pohnert - 通讯作者:
G. Pohnert
Jesmond Dalli的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
- 批准号:82372275
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
Sestrin2抑制内质网应激对早产儿视网膜病变的调控作用及其机制研究
- 批准号:82371070
- 批准年份:2023
- 资助金额:49.00 万元
- 项目类别:面上项目
相似海外基金
Therapeutic approach to confer an anti-tumorigenic role of IL-6 to the pro-tumorigenic cytokine in effector T cells
赋予效应T细胞中促肿瘤细胞因子IL-6抗肿瘤作用的治疗方法
- 批准号:
23K06723 - 财政年份:2023
- 资助金额:
$ 24.26万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
REVAMP-PH: REpurposing Valsartan May Protect against Pulmonary Hypertension
REVAMP-PH:重新利用缬沙坦可以预防肺动脉高压
- 批准号:
10642368 - 财政年份:2023
- 资助金额:
$ 24.26万 - 项目类别:
Neural Mechanisms of Obesity-Induced Hypertension
肥胖引起的高血压的神经机制
- 批准号:
10677977 - 财政年份:2023
- 资助金额:
$ 24.26万 - 项目类别:
Early life stress impacts molecular and network properties that bias the recruitment of pro-stress BLA circuits
早期生活压力会影响分子和网络特性,从而影响促压力 BLA 回路的募集
- 批准号:
10820820 - 财政年份:2023
- 资助金额:
$ 24.26万 - 项目类别:
The impact of alcohol-induced ATF6-mediated ER stress and Golgi disorganization on pro-metastatic glycosylation of integrins in prostate cancer
酒精诱导的 ATF6 介导的 ER 应激和高尔基体解体对前列腺癌整合素促转移糖基化的影响
- 批准号:
10826211 - 财政年份:2023
- 资助金额:
$ 24.26万 - 项目类别:
Functional role of Sec20, a BH3 and Secretory (Sec) domain protein, in neurons and its relevance to a motor neuron disease in Drosophila
Sec20(一种 BH3 和分泌 (Sec) 结构域蛋白)在神经元中的功能作用及其与果蝇运动神经元疾病的相关性
- 批准号:
10635856 - 财政年份:2023
- 资助金额:
$ 24.26万 - 项目类别:
The role of S-glutathione in regulating cardiac myosin binding protein-C function
S-谷胱甘肽在调节心肌肌球蛋白结合蛋白-C功能中的作用
- 批准号:
10749281 - 财政年份:2023
- 资助金额:
$ 24.26万 - 项目类别:
Pathogenesis, prevention and treatment of corticosteroid-resistant gut GVHD
皮质类固醇耐药性肠道GVHD的发病机制及防治
- 批准号:
10585851 - 财政年份:2023
- 资助金额:
$ 24.26万 - 项目类别:
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach
用于治疗胰腺炎的降胆固醇药物:验证具有临床意义的新型治疗靶点和方法
- 批准号:
10585773 - 财政年份:2023
- 资助金额:
$ 24.26万 - 项目类别:
Metabolism and Epigenetic Regulation are Couples in Transdifferentiation and Vascular Regeneration
代谢和表观遗传调控是转分化和血管再生的结合体
- 批准号:
10905167 - 财政年份:2023
- 资助金额:
$ 24.26万 - 项目类别: